CBCC Global Research

CBCC Global Research is a clinical research organization (CRO) dedicated to accelerating the development of medical therapies by providing high-quality, affordable, and strategic solutions for clinical trials. The company operates in the global healthcare market, serving pharmaceutical and biotechnology companies that require comprehensive outsourcing solutions for their clinical studies. CBCC Global Research offers services across all phases of clinical trials, ensuring flawless execution and timely delivery of projects. The business model revolves around a traditional outsourcing methodology, where sponsor companies fully outsource their clinical studies to CBCC Global Research. Revenue is generated through service fees for managing and executing clinical trials. The company emphasizes scientific validity, data integrity, and compliance with regulatory guidelines, aiming to be the partner of choice for medical therapy development services. The Clinical Pharmacology Unit (CPU) is equipped to handle phase 1 clinical studies, including new chemical entities (NCEs), new molecular entities (NMEs), new biological entities (NBAs), and new drug delivery systems (NDDS) based products. Facilities include screening and waiting areas, informed consent rooms, clinical examination rooms, and intensive care beds, among others. CBCC Global Research's close association with medical advisory boards and research communities enables it to address the complexities of clinical trials in specific therapeutic areas.

Keywords: clinical trials, outsourcing, medical therapy, regulatory compliance, data integrity, phase 1 studies, pharmacology, healthcare market, strategic solutions, therapeutic areas.